Regarding endometrial cancer, EMT has been associated with TGF-β, IL-6, CCL18, RANK/RANKL/CCL20, CXCR4/CXCL12, etc. [95], where new treatment possibilities target TGF-β (i.e., a flavonoid Isoliqueritigenin, fluorene-9-bisphenol, etc.)[99,100]. Here, TGFB1 is linked to endometrial cancer.